February 14, 2019
Compounding pharmacy Vital Life Institute LLC, formerly known as AgeVital Pharmacy LLC, will pay $775,000 to resolve claims that the company and its principals paid kickbacks to third-party marketing companies to solicit prospective patients, regardless of the patients’ needs. The investigation was initiated by the filing of a qui tam complaint under the False Claims Act by Manfred Knopf, who received unwanted compounded medications from AgeVital that were billed to Medicare. Mr. Knopf will receive $139,500 as a whistleblower reward. DOJ
Tagged in: Compounding Pharmacy Fraud, FCA Federal, Pharma Fraud, Whistleblower Case, Whistleblower Eligibility, Whistleblower Rewards,